Specifically, CD55 expression has significant correlation with tumor purity in COAD, and the expression of the complement component C3, complement receptor CR4, and complement activation regulator C5aR1 was statistically related with immune purity in STAD (Figure 5). This evidence concerns the gene CD55 and neoplasm.